Approval · Notice of Compliance 1615 · 1999
SENSORCAINE: Notice of Compliance 1615
Issued January 28, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1615
- Date
- January 28, 1999
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths - 0.75%; new indication - sensorcaine 0.75% with/without epinephrine for retrobulbar block
- Therapeutic class
- Local anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE | 02237777 | — |
| SENSORCAINE SPINAL | 02237776 | — |
| SENSORCAINE WITH EPINEPHRINE | 02237778 | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 7.5 MG per ML
- EPINEPHRINE 5 MCG per ML